Literature DB >> 23697371

Does practice make perfect? Results from a Chinese feasibility study of cognitive remediation in schizophrenia.

Linda K Byrne1, Daihui Peng, Marita McCabe, David Mellor, Jie Zhang, Tianhong Zhang, Jia Huang, Yifeng Xu.   

Abstract

Patients with schizophrenia often receive little by way of non-pharmacological interventions. Despite this, promising outcomes in programmes targeting cognitive deficits have been reported, suggesting that this is an area worthy of further investigation. The aim of the study was to implement and evaluate a brief computerised cognitive remediation programme designed to improve memory and attention in a male Chinese sample with chronic schizophrenia. Pre-testing was completed on a number of clinical and cognitive measures for intervention (n = 14) and treatment as usual (n = 17) participants. The intervention group then completed six weeks ( x no. of sessions = 12.78) of the computer-based cognitive remediation programme. Post-test measures for both groups were then collected again. Following the six week intervention, we found, contrary to our expectations, the intervention group improved on several of the clinical variables. The intervention group also performed better than the control group on the post-test measure of attention, but not verbal memory. These findings suggest that it is feasible to improve some aspects of cognitive abilities with a simple computerised training programme for people with serious mental illness.

Entities:  

Mesh:

Year:  2013        PMID: 23697371     DOI: 10.1080/09602011.2013.799075

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  2 in total

1.  Assessment of a six-week computer-based remediation program for social cognition in chronic schizophrenia.

Authors:  Linda K Byrne; Lingyi Pan; Marita McCABE; David Mellor; Yifeng Xu
Journal:  Shanghai Arch Psychiatry       Date:  2015-10

Review 2.  Digital mental health in China: a systematic review.

Authors:  Xiaolong Zhang; Shôn Lewis; Joseph Firth; Xu Chen; Sandra Bucci
Journal:  Psychol Med       Date:  2021-09-28       Impact factor: 7.723

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.